← Home / Alpha Tau Medical Ltd. (DRTS)
Stock Analysis
Alpha Tau Medical Ltd. (DRTS)
DRTS
DRTS · Market data
11.79 -0.84%
Track DRTS in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when DRTS price is:
52W Range Position
83%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:43 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 13.57. Holding above 11.28 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
11.28
↗
Break Above
Confirmation improves above resistance.
13.57
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 11.28
What's Driving DRTS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 13.57 for confirmation and 11.28 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 11.28 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / DOWN
State
Forming
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
13.71
Compression
80%
RSI(14)
48.4
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 11.28 and resistance at 13.71. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
DRTS — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$1.0B
Company size
EV
$991.0M
Debt-adjusted value
P/E
-23.5
Not meaningful
P/B
11.6
Premium
EV/EBIT
-23.4
Not meaningful
P/FCF
-30.6
Not meaningful
FCF Yield
-3.27%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Insufficient
⚖
Balance Sheet
Strong
📈 Net Income
-18.80M
≈ Insufficient
🧮 EPS (Basic)
-0.25
≈ Insufficient
Alpha Tau Medical Ltd.
Related Opportunities